Reviewed,
UniProtKB/Swiss-Prot Q28156 (PDE5A_BOVIN)
Last modified
June 16, 2009.
Version 69.
History...
Clusters with 100%,
90%,
50% identity |
Documents (3) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: cGMP-specific 3',5'-cyclic phosphodiesterase EC=3.1.4.35 Alternative name(s): cGMP-binding cGMP-specific phosphodiesterase Short name=CGB-PDE | ||||
| Gene names |
| ||||
| Organism | Bos taurus (Bovine) | ||||
| Taxonomic identifier | 9913 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Laurasiatheria › Cetartiodactyla › Ruminantia › Pecora › Bovidae › Bovinae › Bos |
Protein attributes
| Sequence length | 865 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP. |
| Catalytic activity | Guanosine 3',5'-cyclic phosphate + H2O = guanosine 5'-phosphate. |
| Cofactor | Divalent cations. Zinc ions yields maximum activity. Manganese, magnesium and cobalt also support catalysis but at much higher concentrations. |
| Enzyme regulation | Most potently inhibited by zaprinast and dipyridamole. |
| Pathway | Purine metabolism; cGMP degradation; GMP from cGMP: step 1/1. |
| Domain | Composed of a C-terminal catalytic domain containing two putative divalent metal sites and an N-terminal regulatory domain which contains two homologous allosteric cGMP-binding regions, A and B. |
| Post-translational modification | Phosphorylation is regulated by binding of cGMP to the two allosteric sites. |
| Sequence similarities | Belongs to the cyclic nucleotide phosphodiesterase family. Contains 2 GAF domains. |
Ontologies
| Keywords | |
|---|---|
| Domain | Repeat |
| Ligand | Magnesium Metal-binding Nucleotide-binding Zinc cGMP cGMP-binding |
| Molecular function | Hydrolase |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Allosteric enzyme Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | cGMP catabolic process Inferred from sequence or structural similarity. Source: AgBase signal transductionInferred from electronic annotation. Source: InterPro |
| Molecular function | 3',5'-cyclic-GMP phosphodiesterase activity Inferred from sequence or structural similarity. Source: AgBase cGMP bindingInferred from sequence or structural similarity. Source: AgBase magnesium ion bindingInferred from electronic annotation. Source: UniProtKB-KW zinc ion bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 865 | 865 | cGMP-specific 3',5'-cyclic phosphodiesterase | PRO_0000198821 | |||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||
| Domain | 154 – 304 | 151 | GAF 1 | ||||||||||||||||||||||||||||||||||||||
| Domain | 336 – 493 | 158 | GAF 2 | ||||||||||||||||||||||||||||||||||||||
| Region | 578 – 843 | 266 | Catalytic By similarity | ||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||
| Metal binding | 607 | 1 | Zinc By similarity | ||||||||||||||||||||||||||||||||||||||
| Metal binding | 643 | 1 | Zinc By similarity | ||||||||||||||||||||||||||||||||||||||
| Metal binding | 644 | 1 | Magnesium By similarity | ||||||||||||||||||||||||||||||||||||||
| Metal binding | 644 | 1 | Zinc By similarity | ||||||||||||||||||||||||||||||||||||||
| Metal binding | 647 | 1 | Magnesium By similarity | ||||||||||||||||||||||||||||||||||||||
| Metal binding | 672 | 1 | Magnesium By similarity | ||||||||||||||||||||||||||||||||||||||
| Metal binding | 754 | 1 | Zinc By similarity | ||||||||||||||||||||||||||||||||||||||
| Binding site | 807 | 1 | cGMP By similarity | ||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||
| Modified residue | 92 | 1 | Phosphoserine Potential | ||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 276 | 1 | N → A: Decreased cGMP-binding; no change in catalytic activity. Ref.4 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 277 | 1 | K → A: Decreased cGMP-binding; no change in catalytic activity. Ref.4 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 277 | 1 | K → R: Slight increase in cGMP-binding. Ref.4 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 289 | 1 | D → A: Decreased cGMP-binding; no change in catalytic activity. Ref.4 Ref.3 Ref.5 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 289 | 1 | D → N: Increased cGMP-binding; no change in catalytic activity. Ref.4 Ref.3 Ref.5 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 290 | 1 | E → A: No change in cGMP-binding. Ref.4 | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 478 | 1 | D → A: Increased cGMP-binding; no change in catalytic activity. Phosphorylated at lower concentrations of cGMP. Ref.3 Ref.5 | ||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||
| Turn | 125 – 127 | 3 | |||||||||||||||||||||||||||||||||||||||
| Helix | 135 – 149 | 15 | |||||||||||||||||||||||||||||||||||||||
| Turn | 155 – 157 | 3 | |||||||||||||||||||||||||||||||||||||||
| Helix | 158 – 170 | 13 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 173 – 180 | 8 | |||||||||||||||||||||||||||||||||||||||
| Turn | 186 – 188 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 189 – 192 | 4 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 194 – 197 | 4 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 211 – 214 | 4 | |||||||||||||||||||||||||||||||||||||||
| Helix | 218 – 226 | 9 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 230 – 233 | 4 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 235 – 237 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 249 – 251 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 254 – 266 | 13 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 268 – 275 | 8 | |||||||||||||||||||||||||||||||||||||||
| Helix | 278 – 280 | 3 | |||||||||||||||||||||||||||||||||||||||
| Helix | 287 – 302 | 16 | |||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone." McAllister-Lucas L.M., Sonnenburg W.K., Kadlecek A., Seger D., Trong H.L., Colbran J.L., Thomas M.K., Walsh K.A., Francis S.H., Corbin J.D., Beavo J.A. J. Biol. Chem. 268:22863-22873(1993) [PubMed: 8226796] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 4-16; 39-55; 90-101; 127-138; 390-409 AND 531-539. Tissue: Lung. |
| [2] | "Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase." Francis S.H., Colbran J.L., McAllister-Lucas L.M., Corbin J.D. J. Biol. Chem. 269:22477-22480(1994) [PubMed: 8077192] [Abstract] Cited for: METAL-BINDING. |
| [3] | "An essential aspartic acid at each of two allosteric cGMP-binding sites of a cGMP-specific phosphodiesterase." McAllister-Lucas L.M., Haik T.L., Colbran J.L., Sonnenburg W.K., Seger D., Turko I.V., Beavo J.A., Francis S.H., Corbin J.D. J. Biol. Chem. 270:30671-30679(1995) [PubMed: 8530505] [Abstract] Cited for: MUTAGENESIS OF ASP-289 AND ASP-478. |
| [4] | "Identification of key amino acids in a conserved cGMP-binding site of cGMP-binding phosphodiesterases. A putative NKXnD motif for cGMP binding." Turko I.V., Haik T.L., McAllister-Lucas L.M., Burns F., Francis S.H., Corbin J.D. J. Biol. Chem. 271:22240-22244(1996) [PubMed: 8703039] [Abstract] Cited for: MUTAGENESIS OF ASN-276; LYS-277; ASP-289 AND GLU-290. |
| [5] | "Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation." Turko I.V., Francis S.H., Corbin J.D. Biochem. J. 329:505-510(1998) [PubMed: 9445376] [Abstract] Cited for: PHOSPHORYLATION, MUTAGENESIS OF ASP-289 AND ASP-478. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L16545 mRNA. Translation: AAB00990.1. | |||||||||||||
| IPI | IPI00710965. | ||||||||||||
| RefSeq | NP_776842.1. | ||||||||||||
| UniGene | Bt.67136 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| SMR | Q28156. Positions 525-850. | ||||||||||||
| ModBase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSBTAG00000024888. Bos taurus. [Contig view] | ||||||||||||
| GeneID | 281972. | ||||||||||||
| KEGG | bta:281972. | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | Q28156. | ||||||||||||
| OMA | Q28156. TPPRFDN. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 3.1.4.35. 251. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR003018. GAF. IPR003607. Met-dep_phosphohydro_HD. IPR002073. PDEase. [Graphical view] | ||||||||||||
| Pfam | PF01590. GAF. 2 hits. PF00233. PDEase_I. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00387. PDIESTERASE1. | ||||||||||||
| SMART | SM00065. GAF. 2 hits. SM00471. HDc. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00126. PDEASE_I. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Entry information
| Entry name | PDE5A_BOVIN | ||||||||
| Accession | Primary (citable) accession number: Q28156 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


